Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$143.3M
-37.4% from 2023
Prescriptions
555K
$258.08 per claim
Patients
177K
70,972 prescribers
Total spending, 2024
$143.4M
$809.56 per patient
Medicare prescription drug plans paid $143.3M for Icosapent Ethyl in 2024, for 555,335 prescriptions and refills to 177,026 patients (down 37.4% from 2023). The average cost per claim was $258.08.
California had the highest Medicare cost for Icosapent Ethyl in 2024: $37.4M for 173,569 claims, followed by New York ($17.1M).
Henrik Khatchatourian, general practice in Glendale, CA, had the highest Medicare cost for Icosapent Ethyl in 2024: 2,487 claims costing $376K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Henrik Khatchatourian Glendale, CA | General Practice | 2,487 | 372 | $376K |
| Hong Liang Rosemead, CA | Internal Medicine | 828 | 315 | $358K |
| Gary Reznik |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 59,808 | 419,895 | 130,984 | $172.8M |
| 2023 | 69,689 | 559,645 | 159,199 | $228.8M |
| 2024 | 70,972 | 555,335 | 177,026 | $143.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 1,850 |
| 252 |
| $306K |
| Anait Galfaian Glendale, CA | Family Practice | 1,680 | 242 | $269K |
| Bosheng Qiu Alhambra, CA | Internal Medicine | 1,298 | 240 | $259K |
| Joann Nguyen San Jose, CA | Family Practice | 767 | 189 | $243K |
| Vlad Nusinovich West Hollywood, CA | Internal Medicine | 1,440 | 181 | $223K |
| Dan V Dang San Jose, CA | Cardiology | 595 | 228 | $193K |
| Narine Arutyounian Glendale, CA | Family Practice | 1,174 | 230 | $183K |
| Khanh B Nguyen Garden Grove, CA | Family Practice | 999 | 143 | $183K |
| Afshine A Emrani Tarzana, CA | Cardiology | 886 | 211 | $181K |
| Zhenghong Yuan San Gabriel, CA | Family Practice | 790 | 192 | $178K |
| Mark Barats West Hollywood, CA | Nephrology | 963 | 108 | $167K |
| Vagharshak M Pilossyan Van Nuys, CA | Internal Medicine | 1,106 | 217 | $166K |
| Sarkis Kiramijyan Glendale, CA | Interventional Cardiology | 865 | 197 | $160K |
| Gevork J Maissian Glendale, CA | Internal Medicine | 847 | 170 | $158K |
| Arutyun Topsakalyan Glendale, CA | General Practice | 927 | 183 | $157K |
| Zaven M Arslanian Glendale, CA | General Practice | 713 | 150 | $145K |
| Hua Ding Flushing, NY | Internal Medicine | 983 | 376 | $143K |
| Vachik Shahnazarian Glendale, CA | General Practice | 821 | 152 | $138K |
| Miguel A Rodriguez Burgos Juncos, PR | Cardiology | 612 | 118 | $138K |
| Bao Q Nguyen Stockton, CA | Family Practice | 485 | 85 | $137K |
| John R Nelson Fresno, CA | Cardiology | 332 | 119 | $136K |
| Ronald G Ryder Hamilton, NJ | Cardiology | 286 | 99 | $131K |
| Manouchehr Rashti Los Angeles, CA | General Practice | 534 | 160 | $121K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Apotex Corp | 147,351 | $34.4M |
| Dr.Reddy'S Lab RDY | 125,782 | $33.7M |
| West-Ward/Hikma HIK.L | 107,683 | $26.1M |
| Camber Pharmace | 38,770 | $12.3M |
| Northstar Rx Ll | 39,178 | $12.0M |
| Epic Pharma LLC | 38,637 | $10.3M |
| Teva USA TEVA | 38,324 | $9.3M |
| Amneal Pharmace AMRX | 16,431 | $4.5M |
| Hikma Pharmaceu HIK.L | 3,206 | $742K |
| Zydus Pharmaceu ZYDUSLIFE.NS | 135 | $38K |
| Avkare | 50 | $4,203 |